-
公开(公告)号:JP2005538924A
公开(公告)日:2005-12-22
申请号:JP2003552695
申请日:2002-12-12
Applicant: ワイスWyeth
Inventor: エリック・スティーブン・マナス , クイジャン・ヤン , ジェイムズ・カール・キース・ジュニア , ヘザー・アン・ハリス , リチャード・エリック・ミューショー , リチャード・ジェイムズ・エドソール , レオ・マッシラマニー・アルバート
IPC: A61P1/04 , A61K31/05 , A61K31/055 , A61K31/085 , A61K31/277 , A61P3/06 , A61P3/10 , A61P5/30 , A61P7/12 , A61P9/00 , A61P9/10 , A61P9/12 , A61P11/00 , A61P11/06 , A61P13/02 , A61P13/08 , A61P13/10 , A61P15/00 , A61P15/02 , A61P15/18 , A61P17/00 , A61P17/06 , A61P19/02 , A61P25/00 , A61P25/22 , A61P25/28 , A61P29/00 , A61P31/04 , A61P35/00 , A61P39/06 , C07C39/14 , C07C39/15 , C07C39/225 , C07C39/24 , C07C39/38 , C07C43/23 , C07C45/68 , C07C49/747 , C07C205/25 , C07C205/26 , C07C255/53 , C07C255/54
CPC classification number: C07C255/54 , C07C39/14 , C07C39/15 , C07C39/38 , C07C43/23 , C07C45/68 , C07C49/747 , C07C205/25 , C07C205/26 , C07C255/53
Abstract: 本発明は、下記構造式(I)を有する式(I)[式中、R
1 、R
2 、R
3 、R
4 、R
5 、R
6 、R
7 、R
8 、R
9 およびR
10 は明細書における定義と同じである]で示されるエストロゲン受容体調節物質またはその医薬上許容される塩を提供する。
【化1】-
公开(公告)号:JP2004515485A
公开(公告)日:2004-05-27
申请号:JP2002547874
申请日:2001-11-28
Applicant: カロ バイオ アクチェブラーグ , メルク アンド カンパニー インコーポレイテッド
Inventor: コーラー,コンラド , ジルナー,ミカエル , チェン,アイピン , ロイド ハモンド,ミルトン , ブイ. ヘック,ジェームズ , トロイ モーズリー,ラルフ , ラヒミ−グハディム,マフムド , リウ,イエ
IPC: C07D211/06 , A61K31/05 , A61K31/122 , A61K31/15 , A61K31/4453 , A61P3/04 , A61P3/06 , A61P9/00 , A61P15/00 , A61P19/00 , A61P19/10 , A61P25/00 , A61P25/28 , A61P35/00 , A61P37/06 , A61P43/00 , C07C39/17 , C07C39/225 , C07C39/23 , C07C43/23 , C07C45/67 , C07C45/68 , C07C49/697 , C07C49/703 , C07C49/727 , C07C49/747 , C07C49/753 , C07C49/755 , C07C251/44 , C07D295/092 , C07F7/18 , C40B40/04
CPC classification number: C07D295/088 , C07C39/17 , C07C39/23 , C07C43/23 , C07C45/673 , C07C45/68 , C07C49/747 , C07C49/753 , C07C251/44 , C07C2602/08 , C07C2603/94
Abstract: 本発明は、式(I)の化合物およびその誘導体(式中、可変の記号は請求項において定義されるとおりである)、それらの合成、およびそれらのエストロゲン受容体調節因子としての使用に関する。 本発明の化合物は、エストロゲン受容体のリガンドであり、それ自体で、エストロゲン機能に関連した様々な状態(骨損失、骨折、骨粗鬆症、軟骨変性、子宮内膜症、子宮筋腫疾患、一過性熱感、LDLコレステロールレベルの増加、循環器疾患、認知機能障害、大脳変性疾患、再狭窄、女性化乳房、自己免疫疾患、血管平滑筋細胞増殖、肥満、失調症、ならびに肺、大腸、乳房、子宮、および前立腺の癌を含む)の治療または予防に有用であり得る。
-
公开(公告)号:JP2554322B2
公开(公告)日:1996-11-13
申请号:JP10324686
申请日:1986-05-07
Applicant: DEYUHON MERUKU PHARM CO ZA
Inventor: DAGURASU GAI BATSUTO
IPC: C12N9/99 , A61K31/00 , A61K31/045 , A61K31/047 , A61K31/05 , A61K31/085 , A61K31/10 , A61K31/12 , A61K31/135 , A61K31/165 , A61K31/17 , A61K31/18 , A61K31/19 , A61K31/215 , A61K31/235 , A61K31/275 , A61K31/415 , A61K31/44 , C07C39/14 , C07C39/17 , C07C39/18 , C07C39/19 , C07C39/225 , C07C39/23 , C07C39/38 , C07C39/42 , C07C43/178 , C07C43/23 , C07C43/295 , C07C43/30 , C07C49/83 , C07C49/84 , C07C59/42 , C07C59/58 , C07C59/68 , C07C59/74 , C07C59/76 , C07C65/01 , C07C65/11 , C07C65/21 , C07C65/24 , C07C69/732 , C07C69/736 , C07C69/738 , C07C69/94 , C07C215/54 , C07C215/86 , C07C235/72 , C07C327/44 , C07C335/32 , C07D207/323 , C07D213/30 , C07D213/50 , C07D233/20 , C07D277/22 , C07D295/08 , C07D295/096 , C07D295/185 , C07D307/42 , C07D307/46 , C07D333/16 , C07D333/22 , C07F7/18 , C07F9/38 , C07F9/40 , C07C59/70 , C07C233/25 , C07C235/66 , C07C311/16 , C07C317/22 , C07C323/18
-
公开(公告)号:JPH08113545A
公开(公告)日:1996-05-07
申请号:JP26914295
申请日:1995-09-22
Applicant: CIBA GEIGY AG
Inventor: SAMIYUERU EBUANSU , SHIYUTEFUAN ARENBATSUHA
IPC: C07C39/21 , C07C39/225 , C07C43/23 , C07C69/14 , C07C69/22 , C07C323/18 , C08K5/00 , C08K5/04 , C09K15/08 , C09K15/14 , C09K15/24 , C10M169/04 , D06M13/02 , D06M13/144 , D06M13/152 , D06M13/224 , D06M13/248 , D06M13/252 , D06M101/00 , D06M101/16 , D06M101/18
-
公开(公告)号:JPH07138201A
公开(公告)日:1995-05-30
申请号:JP28814193
申请日:1993-11-17
Applicant: DAI ICHI KOGYO SEIYAKU CO LTD
Inventor: NAKA AKIHIRO , ITO SHUICHI
IPC: C07C39/225 , C08G59/40 , C08G59/62 , C08L63/00 , C09K3/10
Abstract: PURPOSE:To obtain a new monoallylnaphthol compound useful as a dilluent, a denaturant or a modifier for an epoxy resin curing agent and imparting excellent workability to the agent by lowering the melting point and melt viscosity of the curing agent and capable of providing a cured product free from crack. CONSTITUTION:This compound is a naphthol compound having one ally group expressed by formula I (R is H or OH; when R is H, the position of OH is 2-position, that is, beta-position), e.g. a monoallyl beta-naphthol of formula II. The compound of formula I is obtained by uniformly mixing, e.g. a naphthol with a base and as necessary, an organic solvent to phenoxidize the naphthol, carrying out allylation reaction whole dropping an allyl halide to the solution system for a long time and subjecting the reactional product to Claisen's rearrangement by high-temperature heating. This epoxy resin composition is obtained from the naphthol compound of formula I, an aldehyde condensation product of a naphthol and an epoxy resin. The composition has high glass transition temperature and excellent heat resistance, moisture resistance, adhesiveness and flexibility and it can prevent occurrence of crack in a package.
-
公开(公告)号:JPS63183542A
公开(公告)日:1988-07-28
申请号:JP18867387
申请日:1987-07-28
Applicant: PFIZER
IPC: A61K31/35 , A61K31/05 , A61K31/085 , A61K31/135 , A61K31/335 , A61K31/352 , A61K31/47 , A61P1/08 , A61P1/12 , A61P1/16 , A61P7/10 , A61P11/14 , A61P25/00 , A61P25/04 , A61P25/18 , A61P27/02 , C07C13/60 , C07C27/00 , C07C33/20 , C07C35/22 , C07C39/17 , C07C39/225 , C07C43/178 , C07C43/23 , C07C45/00 , C07C49/755 , C07C67/00 , C07C69/675 , C07C205/33 , C07C213/00 , C07C215/46 , C07C215/64 , C07C217/48 , C07C217/54 , C07C219/28 , C07C229/06 , C07C233/18 , C07C235/32 , C07C235/40 , C07C255/36 , C07C255/37 , C07C255/38 , C07C255/47 , C07C301/00 , C07C311/00 , C07D207/08 , C07D211/34 , C07D307/10 , C07D307/16 , C07D309/04 , C07D311/02 , C07D311/78 , C07D311/92 , C07D455/04 , C07D455/06 , C07D471/04 , C07D491/00 , C07D491/147 , C07D491/16 , C07D495/04
-
公开(公告)号:JPS61263943A
公开(公告)日:1986-11-21
申请号:JP10324686
申请日:1986-05-07
Applicant: DU PONT
Inventor: BATT DOUGLAS GUY
IPC: C12N9/99 , A61K31/00 , A61K31/045 , A61K31/047 , A61K31/05 , A61K31/085 , A61K31/10 , A61K31/12 , A61K31/135 , A61K31/165 , A61K31/17 , A61K31/18 , A61K31/19 , A61K31/215 , A61K31/235 , A61K31/275 , A61K31/415 , A61K31/44 , C07C39/14 , C07C39/17 , C07C39/18 , C07C39/19 , C07C39/225 , C07C39/23 , C07C39/38 , C07C39/42 , C07C43/178 , C07C43/23 , C07C43/295 , C07C43/30 , C07C49/83 , C07C49/84 , C07C59/42 , C07C59/58 , C07C59/68 , C07C59/74 , C07C59/76 , C07C65/01 , C07C65/11 , C07C65/21 , C07C65/24 , C07C69/732 , C07C69/736 , C07C69/738 , C07C69/94 , C07C215/54 , C07C215/86 , C07C235/72 , C07C327/44 , C07C335/32 , C07D207/323 , C07D213/30 , C07D213/50 , C07D233/20 , C07D277/22 , C07D295/08 , C07D295/096 , C07D295/185 , C07D307/42 , C07D307/46 , C07D333/16 , C07D333/22 , C07F7/18 , C07F9/38 , C07F9/40
-
公开(公告)号:JPS60215636A
公开(公告)日:1985-10-29
申请号:JP5468985
申请日:1985-03-20
Applicant: RHONE POULENC SANTE
Inventor: JIERAARU MINIYAANI , DEIDEIE MORERU
IPC: C07C39/06 , B01J31/00 , C07B37/02 , C07B61/00 , C07C27/00 , C07C37/14 , C07C39/08 , C07C39/19 , C07C39/225 , C07C39/24 , C07C39/373 , C07C41/00 , C07C41/30 , C07C43/23 , C07C43/315 , C07C45/00 , C07C47/27 , C07C47/565 , C07C49/835 , C07C67/00 , C07C67/347 , C07C69/013 , C07C69/732 , C07C69/84 , C07C69/92 , C07C201/00 , C07C205/22 , C07C213/08 , C07C215/76 , C07C253/00 , C07C255/36
-
公开(公告)号:JPS5715116B2
公开(公告)日:1982-03-29
申请号:JP8767477
申请日:1977-07-20
IPC: C07C43/23 , C07C27/00 , C07C37/00 , C07C39/18 , C07C39/19 , C07C39/225 , C07C41/00 , C07C45/00 , C07C50/06 , C07C50/14 , C07C67/00 , C07C313/00 , C07C317/18
-
公开(公告)号:JPS5718641A
公开(公告)日:1982-01-30
申请号:JP93181
申请日:1981-01-06
Applicant: TAKEDA CHEMICAL INDUSTRIES LTD
Inventor: TERAO SHINJI , KATOU KANEYOSHI
IPC: C07C43/23 , C07C27/00 , C07C37/00 , C07C39/19 , C07C39/225 , C07C39/23 , C07C41/00 , C07C45/00 , C07C46/00 , C07C50/06 , C07C50/10 , C07C50/26 , C07C67/00
Abstract: PURPOSE:To prepare hydroquinone or a quinone derivative useful as a medicine or its intermediate, by reacting a hydroquinone derivative with a halogenoprenyl derivative, and subjecting the reaction product to reductive elimination reaction, and if necessary, protecting group-elimination reaction and oxidation reaction. CONSTITUTION:A hydroquinone derivative of formula I (R is CH3 or OCH3; or two R together form -CH=CH-CH=CH-; Z is protecting group; Y is arylthio, arylsulfinyl, or arylsulfonyl; n is an integer 1-9) is made to react with a prenyl derivative of formula II (X is halogen; m is an integer 1-9) in an anhydrous organic solvent under basic conditions (e.g. n-butyl lithium) at -78-+20 deg.C to obtain the compound of formula III, which is subjected to the reductive elimination reaction of the Y group, protecting group eliminating reaction, oxidation reaction, etc. to afford the compound of formula IV or formula V [R is CH3 or OCH3; or two R together form -CH=CH-CH=CH- or -CH2-CH=CH-CH2- (in this case, the compound is novel)].
-
-
-
-
-
-
-
-
-